4.38
Finanzdaten der Sionna Therapeutics Inc-Aktie (SION)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
9.70%
32.47
|
29.60 | 23.61 | 23.80 | 21.91 |
| Operating Income/Loss |
9.70%
-32.47
|
-29.60 | -23.61 | -23.80 | -21.91 |
| Nonoperating Income/Loss |
8.37%
2.584
|
2.82 | 3.172 | 3.527 | 3.838 |
| Net Income/Loss |
11.60%
-29.89
|
-26.78 | -20.44 | -20.28 | -18.07 |
| Basic Average Shares |
0.51%
45.15
|
44.92 | 1.5748 | 44.26 | 44.12 |
| Diluted Average Shares |
0.51%
45.15
|
44.92 | 1.5748 | 44.26 | 44.12 |
| Basic Earnings Per Share |
10.00%
-0.66
|
-0.60 | -0.45 | -0.46 | -410.00 |
| Diluted Earnings Per Share |
10.00%
-0.66
|
-0.60 | -0.45 | -0.46 | -410.00 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):